Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$127.00
Provider: ValuEngine, Inc.
$127.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Concord Medical Services Holdings Ltd Signs Framework Agreement To Establish Cancer Specialty Hospital In Beijing International Medical Center


Thursday, 20 Sep 2012 06:00am EDT 

Concord Medical Services Holdings Limited announced that it has signed a framework agreement with Beijing International Medical Center (BIMC) to establish a cancer specialty hospital. Under the agreement, the hospital will be wholly owned by Concord Medical and provide comprehensive cancer therapies, including surgery, chemotherapy, radiotherapy and gene therapy, to high-end cancer patients. Concord Medical will provide management support, treatment, technology and research to the hospital, including protocols and clinical practice guidelines, by collaborating with top-notch cancer institutions around the world. Concord Medical plans to begin designing of the hospital and other early-stage works soon. 

Related Company News

Company Quote

4.12
-0.04 -0.96%
17 May 2013